Assignee profile:

CAMURUS AB

City:

Lund

Country:

Sweden

Published Applications:

54

Last publication date:

2026-01-01

Patent Grants:

33

Last grant date:

2025-06-03

Top Inventors for applications by CAMURUS AB

These are the the leading inventors for applications assigned to CAMURUS AB:

Recent patent applications by CAMURUS AB

CAMURUS AB based in Lund, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-01-01
US20260000730A1
Human necessities

SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS

#2 | 2025-10-23
US20250325626A1
Human necessities

LIPID-CONTROLLED RELEASE COMPOSITIONS

#3 | 2025-10-16
US20250319097A1
Human necessities

PROSTACYCLIN ANALOGUE FORMULATIONS

#4 | 2025-04-17
US20250121035A1
Human necessities

CONTROLLED RELEASE PEPTIDE FORMULATIONS

#5 | 2025-02-13 ✅ Patent 12,318,379 granted on 2025-06-03
US20250049783A1
Human necessities

Opioid formulations

#6 | 2025-02-06 ✅ Patent 12,396,944 granted on 2025-08-26
US20250041205A1
Human necessities

INJECTABLE BUPRENORPHINE FORMULATION

#7 | 2025-01-02
US20250000982A1
Human necessities

PEPTIDE SLOW-RELEASE FORMULATIONS

#8 | 2024-03-07 ✅ Patent 12,161,640 granted on 2024-12-10
US20240075024A1
Human necessities

Opioid formulations

#9 | 2023-11-23
US20230372436A1
Human necessities

SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS

#10 | 2023-09-14
US20230285502A1
Human necessities

MIXTURES AND FORMULATIONS

#11 | 2022-12-08
US20220387445A1
Human necessities

PROSTACYCLIN ANALOGUE FORMULATIONS

#12 | 2022-08-18 ✅ Patent 12,257,282 granted on 2025-03-25
US20220257694A1
Human necessities

Mixtures and formulations

#13 | 2022-06-02 ✅ Patent 11,564,968 granted on 2023-01-31
US20220168381A1
Human necessities

Formulations containing a somatostatin receptor agonist

#14 | 2021-10-07
US20210308226A1
Human necessities

CONTROLLED RELEASE PEPTIDE FORMULATIONS

#15 | 2021-10-07 ✅ Patent 12,029,813 granted on 2024-07-09
US20210308041A1
Human necessities

Injectable buprenorphine formulation

#16 | 2021-09-02
US20210268112A1
Human necessities

PEPTIDE SLOW-RELEASE FORMULATIONS

#17 | 2021-06-17 ✅ Patent 11,135,215 granted on 2021-10-05
US20210177833A1
Human necessities

Opioid formulations

#18 | 2021-05-13 ✅ Patent 11,110,084 granted on 2021-09-07
US20210137916A1
Human necessities

Opioid formulations

#19 | 2021-01-14 ✅ Patent 11,135,264 granted on 2021-10-05
US20210008151A1
Human necessities

Formulations containing a somatostatin receptor agonist

#20 | 2020-11-12
US20200353086A1
Human necessities

CONTROLLED-RELEASE FORMULATIONS

#21 | 2020-11-05 ✅ Patent 10,912,772 granted on 2021-02-09
US20200345719A1
Human necessities

Opioid formulations

#22 | 2020-05-07 ✅ Patent 11,241,476 granted on 2022-02-08
US20200138954A1
Human necessities

Mixtures and formulations comprising an alkyl ammonium EDTA salt

#23 | 2019-11-21
US20190350841A1
Human necessities

LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT

#24 | 2019-08-29 ✅ Patent 10,688,148 granted on 2020-06-23
US20190262419A1
Human necessities

Formulations containing a somatostatin receptor agonist

#25 | 2019-08-22 ✅ Patent 11,369,617 granted on 2022-06-28
US20190255068A1
Human necessities

Prostacyclin analogue formulations

#26 | 2019-02-21
US20190054177A1
Human necessities

PEPTIDE SLOW-RELEASE FORMULATIONS

#27 | 2018-09-13
US20180256496A1
Human necessities

CONTROLLED-RELEASE FORMULATIONS

#28 | 2018-07-26
US20180207089A1
Human necessities

ACID CONTAINING LIPID FORMULATIONS

#29 | 2018-03-22
US20180078647A1
Human necessities

GNRH ANALOGUE FORMULATIONS

#30 | 2017-10-05
US20170281537A1
Human necessities

LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT

#31 | 2015-12-24 ✅ Patent 9,526,788 granted on 2016-12-27
US20150366970A1
Human necessities

Pharmaceutical lipid compositions

#32 | 2015-07-02 ✅ Patent 9,937,164 granted on 2018-04-10
US20150182522A1
Human necessities

Opioid formulations

#33 | 2015-04-16 ✅ Patent 11,672,843 granted on 2023-06-13
US20150105332A1
Human necessities

Somatostatin receptor agonist formulations

#34 | 2014-08-07
US20140219935A1
Human necessities

TOPICAL BIOADHESIVE FORMULATIONS

#35 | 2014-07-10
US20140193347A1
Human necessities

LIPID DEPOT FORMULATIONS

#36 | 2014-07-03 ✅ Patent 9,649,382 granted on 2017-05-16
US20140186279A1
Human necessities

Topical bioadhesive formulations

#37 | 2014-06-12 ✅ Patent 11,433,120 granted on 2022-09-06
US20140162944A1
Human necessities

Controlled release peptide formulations

#38 | 2013-07-25
US20130190341A1
Human necessities

HIGH BIOAVAILABILITY OPIOID FORMULATIONS

#39 | 2012-10-25 ✅ Patent 8,545,832 granted on 2013-10-01
US20120269772A1
Human necessities

Lipid depot formulations

#40 | 2012-02-02 ✅ Patent 9,820,934 granted on 2017-11-21
US20120028890A1
Human necessities

Acid containing lipid formulations

#41 | 2010-08-19 ✅ Patent 9,974,861 granted on 2018-05-22
US20100210519A1
Human necessities

Peptide slow-release formulations

#42 | 2009-07-02 ✅ Patent 9,757,461 granted on 2017-09-12
US20090170782A1
Human necessities

GnRH analogue formulations

#43 | 2008-11-06 ✅ Patent 9,060,935 granted on 2015-06-23
US20080274176A1
Human necessities

Pharmaceutical lipid compositions

#44 | 2008-08-28 ✅ Patent 8,182,834 granted on 2012-05-22
US20080206317A1
Human necessities

Ternary non-lamellar lipid compositions

#45 | 2008-07-03 ✅ Patent 8,541,400 granted on 2013-09-24
US20080161276A1
Human necessities

Compositions forming non-lamellar dispersions

#46 | 2008-06-19 ✅ Patent 8,546,326 granted on 2013-10-01
US20080146490A1
Human necessities

Glp-1 analogue formulations

#47 | 2008-05-29 ✅ Patent 8,097,239 granted on 2012-01-17
US20080124394A1
Human necessities

Controlled-release formulations

#48 | 2008-04-10 ✅ Patent 8,236,292 granted on 2012-08-07
US20080085263A1
Human necessities

Liquid depot formulations

#49 | 2007-12-06 ✅ Patent 8,187,629 granted on 2012-05-29
US20070281030A1
Human necessities

Non-lamellar compositions of DOPE and P80

#50 | 2007-11-15 ✅ Patent 8,236,755 granted on 2012-08-07
US20070265190A1
Human necessities

Opioid depot formulations

#51 | 2007-06-14 ✅ Patent 9,522,377 granted on 2016-12-20
US20070134336A1
Performing operations; transporting

Method for improving the properties of amphiphile particles

#52 | 2007-05-17 ✅ Patent 9,067,190 granted on 2015-06-30
US20070110777A1
Performing operations; transporting

Method for loading amphiphile particles with active agents

#53 | 2007-04-12 ✅ Patent 8,865,021 granted on 2014-10-21
US20070080323A1
Human necessities

Compositions of lipids and cationic peptides

#54 | 2006-04-06
US20060073203A1
Human necessities

Dry polymer and lipid composition

Also check out CAMURUS AB's (Lund, Sweden) applicant profile with 31 patent applications submitted.

AssigneeID:

31808 ⎘